Based on descriptions of more severe COVID-19 in adult CF carriers, who have only one copy of wildtype CFTR, we suggest that this model-based conclusion may be consistent with otherwise normal patient-based experience. The gene discussed is CFTR; the disease is cystic fibrosis.